On the other hand, a possible strength of our study is that a subpopulation of CCs (CD31-CD140b+) correlated with a significantly increased tumor progression hazard for values that were less than or equal to the first quartile, thus, demonstrating a prognostic value for CCs in PanNETs for the first time. This evidence concerns the gene PDGFRB and neoplasm.